| Product Code: ETC7550389 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Patented Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Patented Drugs Market - Industry Life Cycle |
3.4 India Patented Drugs Market - Porter's Five Forces |
3.5 India Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 India Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 India Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India, leading to higher demand for patented drugs. |
4.2.2 Growing healthcare infrastructure and expenditure in the country. |
4.2.3 Supportive government policies and initiatives to promote research and development in the pharmaceutical sector. |
4.3 Market Restraints |
4.3.1 Stringent regulations and lengthy approval processes for patented drugs in India. |
4.3.2 High costs associated with patented drugs, limiting affordability for a significant portion of the population. |
5 India Patented Drugs Market Trends |
6 India Patented Drugs Market, By Types |
6.1 India Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 India Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 India Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 India Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 India Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 India Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 India Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 India Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 India Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 India Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 India Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 India Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 India Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Patented Drugs Market Import-Export Trade Statistics |
7.1 India Patented Drugs Market Export to Major Countries |
7.2 India Patented Drugs Market Imports from Major Countries |
8 India Patented Drugs Market Key Performance Indicators |
8.1 Research and development (RD) investment in the pharmaceutical sector. |
8.2 Number of new drug patents granted in India. |
8.3 Adoption rate of innovative patented drugs in the market. |
8.4 Number of clinical trials conducted for patented drugs in India. |
9 India Patented Drugs Market - Opportunity Assessment |
9.1 India Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 India Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 India Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Patented Drugs Market - Competitive Landscape |
10.1 India Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here